700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ ReadersThis Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Editorial Open Access
For decades, relevant improvements in cancer therapy have occurred, with a significant increase in the overall survival of patients. Nevertheless, with the recent emergence of highly selective molecular targeted agents and high-throughput genomic characterization technologies, robust and well-validated cancer biomarkers are increasingly needed.
Biomarker Research, Cancer